US Patent 10322152 Oncolytic adenovirus encoding a B7 protein
Patent 10322152 was granted and assigned to Psioxus Therapeutics Limited on June, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 31, 2017
Date of Patent
June 18, 2019
Patent Applicant
Patent Application Number
15799644
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10322152 Oncolytic adenovirus encoding a B7 protein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.